临床试验

Coating to Optimize Aneurysm Treatment In The New Flow Diverter Generation

NCT：NCT04870047 · COMPLETED

NCT编号NCT04870047

状态COMPLETED

开始日期2021-09-03

完成时间2025-12-12

SponsorPhenox GmbH (INDUSTRY)

First posted2021-05-03

Last updated2026-09-18

简要摘要

To assess safety and efficacy of p64 MW HPC Flow Modulation Device under single antiplatelet therapy compared to p64 MW Flow Modulation Device under dual antiplatelet therapy.

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态，请参阅官方记录。